ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line

Clinical trial NCT02624895 · COMPLETED

Trial details

NCT number: NCT02624895
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Cancer

Start date: 2015-12-30
Primary completion: 2020-12-31
Enrollment: 296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.